Home » CEPTOR CORPORATION TO RECEIVE $1.5 MILLION FROM JCR PHARMACEUTICALS UPON IND FILING
CEPTOR CORPORATION TO RECEIVE $1.5 MILLION FROM JCR PHARMACEUTICALS UPON IND FILING
CepTor Corporation (OTCBB:CEPO), a development-stage biopharmaceutical company focusing on cell targeted therapeutic products for neuromuscular and neurodegenerative diseases, today announced that it will receive a $1.5 million milestone payment from JCR Pharmaceuticals of Japan upon filing an Investigational New Drug (IND) application for Myodur (C-101) in muscular dystrophy. The payment will include $1 million in equity at the then current market price and $500,000 in cash.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20051020005467&newsLang=en)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May